Incidence of antiplatelet factor 4/heparin antibody induction in patients undergoing percutaneous coronary revascularization.
Gluckman TJ, Segal JB, Fredde NL, Saland KE, Jani JT, Walenga JM, Prechel MM, Citro KM, Zidar DA, Fox E, Schulman SP, Kickler TS, Rade JJ. Incidence of antiplatelet factor 4/heparin antibody induction in patients undergoing percutaneous coronary revascularization. Am J Cardiol. 2005 Mar 15; 95(6):744-7.